Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients

Jakovljevic B. Mihajlo; Miјailovic D. Zeljko; Popovska Jovicic D. Biljana; Canovic S. Predrag; Gajovic M. Olgica; Jovanovic R. Mirjana; Petrovic S. Dejan; Milovanovic Z. Olivera; Djordjevic D. Natasa

doi:10.5812/hepatmon.6750

Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients

Hepatitis Monthly ◽

10.5812/hepatmon.6750 ◽

2013 ◽

Vol 13 (6) ◽

Cited By ~ 6

Author(s):

Jakovljevic B. Mihajlo ◽

Miјailovic D. Zeljko ◽

Popovska Jovicic D. Biljana ◽

Canovic S. Predrag ◽

Gajovic M. Olgica ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Viral Genotype ◽

Costs Of Care ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

The Cost-Effectiveness of Telaprevir Triple Therapy in Treatment of Naïve Chronic Hepatitis C Patients In Turkey

Value in Health ◽

10.1016/j.jval.2014.08.2477 ◽

2014 ◽

Vol 17 (7) ◽

pp. A670

Author(s):

O. Ozdemir

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61114-3 ◽

2012 ◽

Vol 56 ◽

pp. S434 ◽

Cited By ~ 3

Author(s):

S. Curtis ◽

S. Cure ◽

S. Gavart ◽

L. Dearden ◽

J. Fleischmann ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Pegylated Interferon Alfa ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

The Cost-Effectiveness of Telaprevir Triple Therapy in Treatment-Experienced Chronic Hepatitis C Patients in Turkey

Value in Health ◽

10.1016/j.jval.2014.08.2478 ◽

2014 ◽

Vol 17 (7) ◽

pp. A670

Author(s):

O. Ozdemir

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A1

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2002.05481.x ◽

2002 ◽

Vol 97 (2) ◽

pp. 427-434 ◽

Cited By ~ 3

Author(s):

R. Jake Jacobs ◽

Raymond S. Koff ◽

Allen S. Meyerhoff

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A

The American Journal of Gastroenterology ◽

10.1016/s0002-9270(01)04043-6 ◽

2002 ◽

Vol 97 (2) ◽

pp. 427-434

Author(s):

R Jacobs

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis A ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients

Value in Health ◽

10.1016/j.jval.2012.03.1303 ◽

2012 ◽

Vol 15 (4) ◽

pp. A241-A242

Author(s):

S. Cure ◽

S. Curtis ◽

F. Bianic ◽

S. Gavart ◽

L. Dearden ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Pegylated Interferon Alfa ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Value in Health ◽

10.1016/j.jval.2011.08.889 ◽

2011 ◽

Vol 14 (7) ◽

pp. A394-A395

Author(s):

J. Areias ◽

T. Branco ◽

F. Calinas ◽

A. Carvalho ◽

G. Macedo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients

Download Full-text

Evaluating the cost of sustained virologic response in naïve chronic hepatitis C patients treated à la carte

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2007.03419.x ◽

2007 ◽

Vol 26 (5) ◽

pp. 705-716 ◽

Cited By ~ 7

Author(s):

M. BUTI ◽

M. A. CASADO ◽

R. ESTEBAN

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

The Cost ◽

Chronic Hepatitis C Patients ◽

A La Carte

Download Full-text

Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

The European Journal of Health Economics ◽

10.1007/s10198-005-0280-7 ◽

2005 ◽

Vol 6 (2) ◽

pp. 112-123 ◽

Cited By ~ 15

Author(s):

Uwe Siebert ◽

Gaby Sroczynski ◽

Jürgen Wasem ◽

Wolfgang Greiner ◽

Ulrike Ravens-Sieberer ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Initial Treatment ◽

Interferon Α ◽

Competence Network ◽

Analytic Modeling ◽

The Cost ◽

Network Collaboration

Download Full-text

Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France

Value in Health ◽

10.1016/j.jval.2016.09.404 ◽

2016 ◽

Vol 19 (7) ◽

pp. A416

Author(s):

G Sroczynski ◽

A Conrads-Frank ◽

N Mühlberger ◽

F Kühne ◽

G Jeanblanc ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Chronic Hepatitis C Patients

Download Full-text